Literature DB >> 12385681

Bactericidal effects of fatty acids and monoglycerides on Helicobacter pylori.

Gudmundur Bergsson1, Olafur Steingrímsson, Halldor Thormar.   

Abstract

The susceptibility of Salmonella spp., Escherichia coli and Helicobacter pylori to fatty acids and monoglycerides was studied. None of the lipids showed significant antibacterial activity against Salmonella spp. and E. coli but eight of 12 lipids tested showed high activity against H. pylori, monocaprin and monolaurin being the most active. The high activity of monoglycerides against H. pylori suggests that they may be useful as active ingredients in pharmaceutical formulations.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12385681     DOI： 10.1016/s0924-8579(02)00205-4

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


  21 in total

1.  Stable concentrated emulsions of the 1-monoglyceride of capric acid (monocaprin) with microbicidal activities against the food-borne bacteria Campylobacter jejuni, Salmonella spp., and Escherichia coli.

Authors:  Halldor Thormar; Hilmar Hilmarsson; Gudmundur Bergsson
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Viscoelastic properties of a virucidal cream containing the monoglyceride monocaprin: effects of formulation variables: a technical note.

Authors:  Thórunn Osk Thorgeirsdóttir; Halldór Thormar; Thórdís Kristmundsdóttir
Journal:  AAPS PharmSciTech       Date:  2006-05-12       Impact factor: 3.246

3.  Characterization of medium chain length (R)-3-hydroxycarboxylic acids produced by Streptomyces sp. JM3 and the evaluation of their antimicrobial properties.

Authors:  Adrian Douglas Allen; Patrick Daley; Folahan O Ayorinde; Ayelle Gugssa; Winston A Anderson; Broderick E Eribo
Journal:  World J Microbiol Biotechnol       Date:  2012-06-19       Impact factor: 3.312

4.  In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.

Authors:  Mark S Rouse; Margalida Rotger; Kerryl E Piper; James M Steckelberg; Matthew Scholz; Jeffrey Andrews; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Effects of medium-chain fatty acids on the structure and immune response of IPEC-J2 cells.

Authors:  B Martínez-Vallespín; W Vahjen; J Zentek
Journal:  Cytotechnology       Date:  2016-08-23       Impact factor: 2.058

6.  In vitro effect of C2-C18 fatty acids on Salmonellas.

Authors:  E Skrivanová; O G Savka; M Marounek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

7.  In vitro and in vivo antimicrobial activity of granulysin-derived peptides against Vibrio cholerae.

Authors:  Ana Paula Galvão da Silva; Donovan Unks; Shu-chen Lyu; Jeffrey Ma; Renata Zbozien-Pacamaj; Xi Chen; Alan M Krensky; Carol Clayberger
Journal:  J Antimicrob Chemother       Date:  2008-02-29       Impact factor: 5.790

8.  Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization.

Authors:  Marta Correia; Valérie Michel; António A Matos; Patrícia Carvalho; Maria J Oliveira; Rui M Ferreira; Marie-Agnès Dillies; Michel Huerre; Raquel Seruca; Ceu Figueiredo; Jose C Machado; Eliette Touati
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

9.  Synthesis and characterization of Fatty acid/amino Acid self-assemblies.

Authors:  Joanna Gajowy; Durgadas Bolikal; Joachim Kohn; Miroslawa El Fray
Journal:  J Funct Biomater       Date:  2014-10-24

10.  Oral mucosal lipids are antibacterial against Porphyromonas gingivalis, induce ultrastructural damage, and alter bacterial lipid and protein compositions.

Authors:  Carol L Fischer; Katherine S Walters; David R Drake; Deborah V Dawson; Derek R Blanchette; Kim A Brogden; Philip W Wertz
Journal:  Int J Oral Sci       Date:  2013-07-19       Impact factor: 6.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.